BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37824368)

  • 1. Whole-Genome Comparative Copy Number Alteration Profiling between Malignant Pleural Mesothelioma and Asbestos-Induced Chronic Pleuritis.
    Tuncel T; Metintas M; Güntülü AK; Güneş HV
    J Environ Pathol Toxicol Oncol; 2024; 43(1):31-44. PubMed ID: 37824368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.
    Borczuk AC; Pei J; Taub RN; Levy B; Nahum O; Chen J; Chen K; Testa JR
    Cancer Biol Ther; 2016; 17(3):328-35. PubMed ID: 26853494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
    Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
    Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
    Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
    BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma.
    Hylebos M; Van Camp G; Vandeweyer G; Fransen E; Beyens M; Cornelissen R; Suls A; Pauwels P; van Meerbeeck JP; Op de Beeck K
    Oncotarget; 2017 Dec; 8(69):113673-113686. PubMed ID: 29371938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure.
    Tuncel T; Ak G; Güneş HV; Metintaş M
    J Environ Pathol Toxicol Oncol; 2024; 43(2):13-27. PubMed ID: 38505910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal deletion in patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Sugarbaker DJ
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.
    Chirac P; Maillet D; Leprêtre F; Isaac S; Glehen O; Figeac M; Villeneuve L; Péron J; Gibson F; Galateau-Sallé F; Gilly FN; Brevet M
    Hum Pathol; 2016 Sep; 55():72-82. PubMed ID: 27184482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization.
    Chang YC; Yeh KT; Liu TC; Chang JG
    J Clin Lab Anal; 2010; 24(3):167-74. PubMed ID: 20486198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study.
    Crovella S; Bianco AM; Vuch J; Zupin L; Moura RR; Trevisan E; Schneider M; Brollo A; Nicastro EM; Cosenzi A; Zabucchi G; Borelli V
    J Toxicol Environ Health A; 2016; 79(3):129-41. PubMed ID: 26818092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite).
    Erzen C; Eryilmaz M; Kalyoncu F; Bilir N; Sahin A; Baris YI
    J Comput Assist Tomogr; 1991; 15(2):256-60. PubMed ID: 1848247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
    Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V
    Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes.
    Celsi F; Crovella S; Moura RR; Schneider M; Vita F; Finotto L; Zabucchi G; Zacchi P; Borelli V
    J Toxicol Environ Health A; 2019; 82(20):1088-1102. PubMed ID: 31755376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy number gains in malignant pleural mesothelioma.
    Furukawa M; Toyooka S; Hayashi T; Yamamoto H; Fujimoto N; Soh J; Hashida S; Shien K; Asano H; Aoe K; Okabe K; Pass HI; Tsukuda K; Kishimoto T; Miyoshi S
    Oncol Lett; 2015 Nov; 10(5):3274-3278. PubMed ID: 26722325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATG5 as biomarker for early detection of malignant mesothelioma.
    Tomasetti M; Monaco F; Strogovets O; Volpini L; Valentino M; Amati M; Neuzil J; Santarelli L
    BMC Res Notes; 2023 Apr; 16(1):61. PubMed ID: 37095543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of preclinical models for malignant pleural mesothelioma.
    Shamseddin M; Obacz J; Garnett MJ; Rintoul RC; Francies HE; Marciniak SJ
    Thorax; 2021 Nov; 76(11):1154-1162. PubMed ID: 33692175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.